The environmental impact of medtech


The medtech industry strives to work in a sustainable and responsible fashion to produce innovative products while preserving the environment.

Our members are committed to meeting high standards and engaging with regulators to ensure a net benefit for the environment, human health and society based on the principles of science, regulatory certainty and proportionality.The EU has strong environmental regulation. This is reflected not just in environmental law but is evident throughout European legislation. The directives covering medical devices and in vitro diagnostics (IVDs) include stringent rules on manufacturing processes and the quality of products placed on the market. 

Environmental legislation (for example, WEEE, RoHS and REACH) places further significant requirements on products across their lifecycle. These include regulating the use of hazardous substances, necessitating detailed environmental reporting and setting targets for the re-use, recovery and recycling of e-waste.

 

Position paper

Recommendations by an EU-wide cross-industry initiative for better regulation in chemicals management

EDMA and Eucomed are signatories to the Cross Industry Initiative (CII) that developed a concrete set of proposals aimed at achieving better regulation in chemicals management. The streamlined position paper addresses in particular the situation when potential risks of a substance are limited to the workplace and can be more effectively addressed by workplace-specific legislation. The position paper explains how to implement and enforce the most effective risk management options that are tailored to tackle a specific risk.